Artificial Life Inc. is a leading full service provider of award-winning mobile technology, games, and applications. Founded in 1994, Artificial Life Inc. went public in 1998. Headquartered in Santa Monica, California, the company has their production center in Hong Kong as well as additional offices in Berlin, Germany, and a sales office in Tokyo, Japan.

Artificial Life provides mobile broadband 3G technology, mobile participation TV, mobile gaming, content, and mobile business applications. They also provide mobile advertisement and product placements and mobile aggregation and distribution. Artificial Life provides 2D and 3D multi- and single player rich-media applications for 3G, 3.5G/HSDPA and 4G network-enabled mobile phones. The company has received recognition internationally for outstanding content quality and technology.

Artificial Life announced in 2008 that their mobile development tool MobileBooster™ now extends its support to the iPhone® and iPod® touch platforms. Created by Artificial Life for mobile 2G/3G applications and games, MobileBooster™

...

Stockerblog.com had the pleasure of recently interviewing Natalie Pace, head of her own financial publishing and media company, and author of the book a href=”http://www.amazon.com/gp/product/1593154917?ie=UTF8tag=antiquestocka-20linkCode=as2camp=1789creative=9325creativeASIN=1593154917″Put Your Money Where Your Heart Is: Investment Strategies for Lifetime Wealth from a #1 Wall Street Stock Picker/aimg src=”http://www.assoc-amazon.com/e/ir?t=antiquestocka-20l=as2o=1a=1593154917″ width=”1″ height=”1″ border=”0″ alt=”" style=”border:none !important; margin:0px !important;” /. She has been a repeat guest on Fox News, Forbes on Fox, Good Morning America, Time Magazine, USA Today, Kiplinger’s Personal Finance, and other financial news media.br /br /span style=”font-weight:bold;”Stockerblog.com/span: What made you decide to get into stock investing, after losing money on real estate? In other words, why not just put your money in the bank?br /br /span style=”font-weight:bold;”Pace:/span I didn’t lose money on real estate, I was underwater and when I did sell my real estate, I sold for a profit. And in the mean time, I was able to live there and not pay …

I’m writing this from a hotel room in Santa Monica in California. I’m on holiday here with my lovely wife Lynn and our two equally gorgeous daughters, Eilish and Maddie, and am about to embark on an RV trip across America to Orlando in Florida.

Lynn will attend a conference on digital scrapbooking at Disneyland in Orlando in a fortnight if we make it. I’ll tell her story about how she came to be a digital design exporter (earning a lot more than me…) in this blog at a later date.  Suffice to say, this trip will more than pay for itself in US dollar earnings.

I’ll try to blog about the trip and what I learn from an economic and business point of view as often as I can. It should turn out a lot easier to do than in New Zealand. Free cable broadband or WiFi access

...

As part of our Hedge Fund Startup Guide please see our list of hedge fund backers below: Affiliated Managers Group Boston Brett Perryman Public company has taken equity stakes in four hedge fund shops: AQR Capital, Blue Mountain, First Quadrant and Value Act. Asset Alliance New York Bruce Lipnick Twice has backed off plans to sell stock to the public, most recently in August and in 1998. Offers operational and marketing support in exchange for 50% ownership of management companies. BRI Partners Chicago Adam Brass Provides investment capital in exchange for marketing and operational support. Boxtree Capital Rumson N.J. Robert Picard 732-939-9000 Founded earlier this year by former Optima Fund Management chief investment officer Robert Picard, the firm has not yet made any acquisitions. Hopes to buy minority interests in funds of funds and ...

In last quarter’s letter, we discussed the Fund’s purchase of shares of Sanofi-Aventis S.A. (“Sanofi”), one of the largest pharmaceutical companies in the world. Numerous issues which are clouding the outlook for the pharmaceutical industry – including a stricter Food and Drug Administration, the upcoming Presidential Election in the U.S., intensifying generic competition, and the ongoing push by governments to contain health care costs – in addition to company specific issues, enabled Fund management to purchase shares of this well-financed, highly profitable and cash generative business at what we believe is an attractive valuation, without attributing any value to Sanofi’s pipeline. While we believe Sanofi represents an attractive investment opportunity for the Fund on a stand-alone basis, the company, and the pharmaceutical industry ingeneral, are subject to inherent uncertainties whose outcomes are difficult to predict with a high degree of certainty.

One of the most notable of these uncertainties is

...